Scientists uncover promising new way to treat an ‘undruggable’ type of lung cancer
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Good News for Lung Cancer Patients
New research from the 2026 American Society of Clinical Oncology (ASCO) annual meeting, and presented on Cure Today, highlights an encouraging new treatment on the horizon for advanced non-small cell lung cancer (NSCLC), the most common type of lung cancer. An early-stage clinical trial looked at an experimental drug called pumitamig. For patients who do […]
Patients with KRAS-G13C mutated lung cancer cannot yet be specifically treated. A selective active substance has now greatly reduced the growth of cancer cells and achieved great treatment successes in combination with chemotherapy in preclinical cancer models. The transition to the clinic could "be quite fast." Manchester (England). Non-Small Cell Lung Cancer (NSCLC) accounts for about 85 percent of all lung cancer cases, i.e. around 1.5 millio…
Scientists uncover promising new way to treat an ‘undruggable’ type of lung cancer
Breakthrough research led by scientists in Manchester has identified a new drug combination that could improve outcomes for thousands of patients with lung cancer driven by a rare type of KRAS mutation, offering hope for patients worldwide with this difficult-to-treat subtype of lung cancer.A study published in Cancer Discovery, focuses on non-small cell lung cancer (NSCLC) which accounts for around 20% of cancer-related deaths worldwide. Mutati…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
